Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 82 NE 26th St Unit 110 MIAMI FL 33137-4442 |
Tel: | 1-720-3302829 |
Website: | cansortium.com |
IR: | See website |
Key People | ||
William Smith Executive Chairman of the Board | Robert Beasley Chief Executive Officer, Director | Jeffrey Batliner Chief Financial Officer |
Samantha Hymes Executive Vice President | Victor Bindi Sales Director | Todd Buchman Chief Legal Officer and Corporate Secretary |
Business Overview |
Cansortium Inc. is a vertically integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the private label, Fluent. The Company, through its subsidiaries, is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The Company's medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges and edibles and accessories. The Company's subsidiaries include Cansortium Holdings LLC, Cansortium Pennsylvania, LLC, Cansortium Puerto Rico, LLC, Cansortium Texas, LLC, Cansortium Canada Holdings Inc., Fluent Servicing, LLC, Cansortium Florida, LLC., Spirit Lake Road Nursery, LLC, Harvest Park Lot 9 Investors LLC, Fluent Hemp LLC and Cansortium Michigan LLC. |
Financial Overview |
For the nine months ended 30 September 2023, Cansortium Inc revenues increased 12% to $71.7M. Net loss before extraordinary items decreased 19% to $15.5M. Revenues reflect Pharmaceuticals segment increase from $22.1M to $49.7M, United States segment increase from $22.1M to $49.7M. Lower net loss reflects Pharmaceuticals segment income increase from $1.2M to $6.1M, United States segment income increase from $1.2M to $6.1M. |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $134.64M as of Sep 30, 2023 |
Annual revenue (TTM): | $95.21M as of Sep 30, 2023 |
EBITDA (TTM): | $52.25M as of Sep 30, 2023 |
Net annual income (TTM): | -$33.51M as of Sep 30, 2023 |
Free cash flow (TTM): | $14.83M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | $85.67M as of Sep 30, 2023 |
Shares outstanding: | 299,529,367 as of Nov 14, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |